Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cancer Research

• Publication date

  2009-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1158/0008-5472.CAN-09-0540PMID 19671798
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteomic characterization of cytoskeletal and mitochondrial class III β-tubulin

  2008influential reference
• Detecting protein–protein interactions by far western blotting

  2007cited by this paper
• Bcl-2 expression as a predictive marker of hormone-refractory prostate cancer treated with taxane-based chemotherapy

  2007cited by this paper
• Microtubules in apoptosis induction: are they necessary?

  2007cited by this paper
• Assay for apoptosis using the mitochondrial probes, Rhodamine123 and 10-N-nonyl acridine orange

  2007cited by this paper
• Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients.

  2006cited by this paper
• Class III β-Tubulin Overexpression Is a Marker of Poor Clinical Outcome in Advanced Ovarian Cancer Patients

  2006cited by this paper
• Bcl-2 Expression as a Predictive Marker of Hormone-Refractory Prostate Cancer Treated with Taxane-Based Chemotherapy

  2006cited by this paper
• Bcl-2 Is a Prognostic Marker in Breast Cancer Independently of the Nottingham Prognostic Index

  2006cited by this paper
• The role of apoptosis in cancer development and treatment response

  2005cited by this paper
• HIV-1 Tat protein enhances Microtubule polymerization

  2005cited by this paper
• Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients.

  2005cited by this paper
• Using a β‐Hairpin To Mimic an α‐Helix: Cyclic Peptidomimetic Inhibitors of the p53–HDM2 Protein–Protein Interaction

  2004cited by this paper
• Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3.

  2004cited by this paper
• The bioactive Taxol conformation on beta-tubulin: experimental evidence from highly active constrained analogs.

  2004cited by this paper
• Using a beta-hairpin to mimic an alpha-helix: cyclic peptidomimetic inhibitors of the p53-HDM2 protein-protein interaction.

  2004cited by this paper
• Class III B-Tubulin Overexpression Is a Prominent Mechanism of Paclitaxel Resistance in Ovarian Cancer Patients

  2004cited by this paper
• The seco-taxane IDN5390 is able to target class III beta-tubulin and to overcome paclitaxel resistance.

  2004cited by this paper
• Microtubule-targeted anticancer agents and apoptosis

  2003cited by this paper
• Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance.

  2003influential reference
• Synthesis and biological evaluation of 2'-methyl taxoids derived from baccatin III and 14beta-OH-baccatin III 1,14-carbonate.

  2003cited by this paper
• ELM server: a new resource for investigating short functional sites in modular eukaryotic proteins

  2003cited by this paper
• A multimeric model for murine anti-apoptotic protein Bcl-2 and structural insights for its regulation by post-translational modification.

  2003cited by this paper
• Apoptosis Genes and Resistance to Cancer Therapy: What Does the Experimental and Clinical Data Tell Us?

  2003cited by this paper
• HIV‐1 Tat targets microtubules to induce apoptosis, a process promoted by the pro‐apoptotic Bcl‐2 relative Bim

  2002cited by this paper
• Refined structure of alpha beta-tubulin at 3.5 A resolution.

  2001cited by this paper
• The binding conformation of Taxol in β-tubulin: A model based on electron crystallographic density

  2001cited by this paper
• The role of beta-tubulin isotypes in resistance to antimitotic drugs.

  2001cited by this paper
• Paclitaxel induces release of cytochrome c from mitochondria isolated from human neuroblastoma cells'.

  2000cited by this paper
• Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3.

  2000cited by this paper
• BCL-2 and glutathione: alterations in cellular redox state that regulate apoptosis sensitivity.

  1999influential reference
• Screening of a library of phage-displayed peptides identifies human bcl-2 as a taxol-binding protein.

  1999cited by this paper
• "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.

  1998cited by this paper
• Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux.

  1998influential reference
• Identification of a novel regulatory domain in Bcl‐xL and Bcl‐2

  1997cited by this paper
• Microtubule‐active drugs suppress the closure of the permeability transition pore in tumour mitochondria

  1996cited by this paper
• Taxol induces bcl-2 phosphorylation and death of prostate cancer cells.

  1996cited by this paper
• Idiotypic mimicry and the assembly of a supramolecular structure: an anti-idiotypic antibody that mimics taxol in its tubulin-microtubule interactions.

  1994cited by this paper
• Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations.

  1993cited by this paper
• Promotion of microtubule assembly in vitro by taxol

  1979cited by this paper

• First structural Elucidation of Bcl-2 functional conversion induced by validated modulators using microsecond-scale molecular dynamics simulations and density functional theory.

  2026cites this paper
• 7'-Hydroxyl substituted xanthones from Gentianella acuta revert hepatic steatosis in obese diabetic mice through preserving mitochondrial homeostasis.

  2025cites this paper
• Cephalomannine as in vitro and in vivo anticancer agent in mesothelioma cells: mechanisms of action

  2025cites this paper
• Pancreatic Cancer Organoids: Modeling Disease and Guiding Therapy

  2025cites this paper
• Paclitaxel-induced adverse effects: insights into multi-organ toxicities and molecular mechanisms

  2025cites this paper
• Paclitaxel loaded mitochondrial targeting virus mimicking polymeric nanosystem for tackling triple-negative breast cancer

  2025cites this paper
• Pyrazoline B-Paclitaxel or Doxorubicin Combination Drugs Show Synergistic Activity Against Cancer Cells: In silico Study

  2024cites this paper
• Imbalance between Actin Isoforms Contributes to Tumour Progression in Taxol-Resistant Triple-Negative Breast Cancer Cells

  2024cites this paper
• Text-mining-based feature selection for anticancer drug response prediction

  2024cites this paper
• Interplay between paclitaxel, gap junctions, and kinases: unraveling mechanisms of action and resistance in cancer therapy

  2024cites this paper
• Liposomal Nanoformulation-encapsulated Paclitaxel for Reducing Chemotherapy Side Effects in Lung Cancer Treatments: Recent Advances and Future Outlooks.

  2024cites this paper
• A NOVEL STEP TOWARDS THE HETEROLOGOUS BIOSYNTHESIS OF PACLITAXEL: CHARACTERIZATION OF T1βOH TAXANE HYDROXYLASE.

  2024cites this paper
• Activation of the PERK/eIF2α axis is a pivotal prerequisite of taxanes to cancer cell apoptosis and renders synergism to overcome paclitaxel resistance in breast cancer cells

  2024cites this paper
• Microtubule Dynamics Deregulation Induces Apoptosis in Human Urothelial Bladder Cancer Cells via a p53-Independent Pathway

  2023cites this paper
• Physiological and metabolic traits of Taxol biosynthesis of endophytic fungi inhabiting plants: Plant-microbial crosstalk, and epigenetic regulators.

  2023cites this paper
• Cancer Therapy Empowered by Extracellular Vesicle-Mediated Targeted Delivery.

  2023cites this paper
• FBXL2 promotes E47 protein instability to inhibit breast cancer stemness and paclitaxel resistance

  2022cites this paper
• Misoprostol alleviates paclitaxel-induced liver damage through its antioxidant and anti-apoptotic effects

  2022cites this paper
• Phytochemical Targeting of Mitochondria for Breast Cancer Chemoprevention, Therapy, and Sensitization

  2022cites this paper
• Neurophysiopathological Aspects of Paclitaxel-induced Peripheral Neuropathy

  2022cites this paper
• Relationship between the microRNAs and PI3K/AKT/mTOR axis: Focus on non-small cell lung cancer.

  2022cites this paper
• A synthetic prostaglandin E1 analogue, misoprostol, ameliorates paclitaxel-induced oxidative damage in rat brain.

  2022cites this paper
• Therapeutic Strategies for Ovarian Cancer in Point of HGF/c-MET Targeting

  2022cites this paper
• Molecular mechanisms by which splice modulator GEX1A inhibits leukaemia development and progression

  2022cites this paper
• Mechanisms of chemotherapy resistance in ovarian cancer

  2022cites this paper
• Molecular mechanisms associated with chemoresistance in esophageal cancer

  2022cites this paper
• Antiviral Drug 2-thio-6-azauridine Sensitizes Paclitaxel-Resistant Triple Negative Breast Cancer Cells by Targeting Mammosphere Formation and ABC Transporters

  2022cites this paper
• Taxol: Mechanisms of action against cancer, an update with current research

  2022cites this paper
• Current Perspectives on Taxanes: Focus on Their Bioactivity, Delivery and Combination Therapy

  2021cites this paper
• Co-Delivery of Paclitaxel and shMCL-1 by Folic Acid-Modified Nonviral Vector to Overcome Cancer Chemotherapy Resistance.

  2021cites this paper
• Chemotherapeutic drugs: Cell death- and resistance-related signaling pathways. Are they really as smart as the tumor cells?

  2021cites this paper
• Microtubule Targeting Agents in Disease: Classic Drugs, Novel Roles

  2021cites this paper
• Do Lipid-based Nanoparticles Hold Promise for Advancing the Clinical Translation of Anticancer Alkaloids?

  2021cites this paper
• Mitochondria-Targeted Nanomedicine for Enhanced Efficacy of Cancer Therapy

  2021cites this paper
• βIII-tubulin overexpression in cancer: Causes, consequences, and potential therapies.

  2021cites this paper
• Nab-paclitaxel promotes the cancer-immunity cycle as a potential immunomodulator.

  2021cites this paper
• Malayoside, a Cardenolide Glycoside Extracted from Antiaris Toxicaria Lesch, Induces Apoptosis in Human Non-small Lung Cancer Cells via MAPK-Nur77 Signaling Pathway.

  2021cites this paper
• Y-320, a novel immune-modulator, sensitizes multidrug-resistant tumors to chemotherapy.

  2020cites this paper
• In Vitro Effects of Paclitaxel and Cremophor EL on Human Riboflavin Transporter SLC52A2.

  2020cites this paper
• Truncated HDAC9 identified by integrated genome-wide screen as the key modulator for paclitaxel resistance in triple-negative breast cancer

  2020cites this paper
• Design, synthesis, and biological evaluation of 5-((8-methoxy-2-methylquinolin-4-yl)amino)-1H-indole-2-carbohydrazide derivatives as novel Nur77 modulators.

  2020cites this paper
• Flavaglines as natural products targeting eIF4A and prohibitins: From traditional Chinese medicine to antiviral activity against coronaviruses

  2020cites this paper
• Highly Conserved Homotrimer Cavity Formed by the SARS-CoV-2 Spike Glycoprotein: A Novel Binding Site

  2020cites this paper
• Preparation and characterization of extracellular vesicles for cancer therapy

  2020cites this paper
• Microtubule-targeting agents and their impact on cancer treatment.

  2020cites this paper
• A Compressive Review about Taxol®: History and Future Challenges

  2020cites this paper
• The Paradoxical Roles of Orphan Nuclear Receptor 4A (NR4A) in Cancer

  2020cites this paper
• Resistance to paclitaxel is associated with a variant of the gene BCL2 in multiple tumor types

  2019cites this paper
• Tumor suppressor microRNAs in lung cancer: An insight to signaling pathways and drug resistance

  2019cites this paper
• Regulating the BCL2 Family to Improve Sensitivity to Microtubule Targeting Agents

  2019cites this paper
• Shedding Light on the Interaction of Human Anti-Apoptotic Bcl-2 Protein with Ligands through Biophysical and in Silico Studies

  2019influential citation
• Resistance to anti-tubulin agents: From vinca alkaloids to epothilones

  2019cites this paper
• Current progress in antimalarial pharmacotherapy and multi-target drug discovery.

  2019cites this paper
• PRP4K IS A NOVEL HER2-REGULATED MODIFIER OF ANOIKIS AND TAXANE RESISTANCE

  2018influential citation
• New Drug Candidate Targeting the 4A1 Orphan Nuclear Receptor for Medullary Thyroid Cancer Therapy

  2018influential citation
• B cell lymphoma 2 (Bcl-2) residues essential for Bcl-2's apoptosis-inducing interaction with Nur77/Nor-1 orphan steroid receptors

  2018cites this paper
• Triphenylphosphine-docetaxel conjugate-incorporated albumin nanoparticles for cancer treatment.

  2018cites this paper
• FLIM reveals alternative EV‐mediated cellular up‐take pathways of paclitaxel

  2018cites this paper
• LncRNA TDRG1 enhances tumorigenicity in endometrial carcinoma by binding and targeting VEGF-A protein.

  2018cites this paper
• Screening of endophytic fungi stored in a culture collection for taxol production

  2018cites this paper
• Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells

  2018cites this paper
• Paclitaxel Enhances Oncolytic Potential of Herpes Simplex Virus Type-1 in Cancer Cells

  2018influential citation
• Predictive Value of Epigenetic Signatures

  2018cites this paper
• Interactome Analysis of Microtubule-targeting Agents Reveals Cytotoxicity Bases in Normal Cells

  2017cites this paper
• Structurally simplified biphenyl combretastatin A4 derivatives retain in vitro anti-cancer activity dependent on mitotic arrest

  2017cites this paper
• Review of Cytotoxic CA4 Analogues that Do Not Target Microtubules: Implications for CA4 Development.

  2017cites this paper
• The NR4A subfamily of nuclear receptors: potential new therapeutic targets for the treatment of inflammatory diseases

  2017cites this paper
• Neurotoxic mechanisms of paclitaxel are local to the distal axon and independent of transport defects

  2017cites this paper
• The long unstructured region of Bcl‐xl modulates its structural dynamics

  2017cites this paper
• Modulation of the Nur77-Bcl-2 apoptotic pathway by p38α MAPK

  2017cites this paper
• Microtubule Targeting Agents in Cancer Therapy: Elucidating the Underlying Molecular Mechanisms

  2017cites this paper
• Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides

  2017cites this paper
• Surface Plasmon Resonance technology to assess biological interactions

  2017cites this paper
• The kinesin spindle protein inhibitor filanesib enhances the activity of pomalidomide and dexamethasone in multiple myeloma

  2017cites this paper
• Orphan Nuclear Receptor NR4A1 Binds a Novel Protein Interaction Site on Anti-apoptotic B Cell Lymphoma Gene 2 Family Proteins*

  2016cites this paper
• Development of novel cyclic peptides as pro-apoptotic agents.

  2016cites this paper
• Nuclear receptor 4A (NR4A) family - orphans no more.

  2016cites this paper
• Targeting highly expressed extracellular HSP90 in breast cancer stem cells inhibits tumor growth in vitro and in vivo

  2016cites this paper
• NR4A1 Antagonists Inhibit β1-Integrin-Dependent Breast Cancer Cell Migration

  2016cites this paper
• Investigating the Neuroprotective Effects of Turmeric Extract: Structural Interactions of β-Amyloid Peptide with Single Curcuminoids

  2016cites this paper
• A novel inhibitor of BCL2, Disarib abrogates tumor growth while sparing platelets, by activating intrinsic pathway of apoptosis.

  2016cites this paper
• Neurotoxic Mechanisms of the Chemotherapeutic Paclitaxel

  2016influential citation
• Microtubule‐Binding Proteins as Promising Biomarkers of Paclitaxel Sensitivity in Cancer Chemotherapy

  2016cites this paper
• Development of a practical and scalable route for the preparation of the deacetoxytubuvaline (dTuv) fragment of pretubulysin and analogs

  2016cites this paper
• Microtubule-stabilizing properties of the avocado-derived toxins (+)-(R)-persin and (+)-(R)-tetrahydropersin in cancer cells and activity of related synthetic analogs

  2016cites this paper
• Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning

  2016cites this paper
• Use of Integrated Computational Approaches in the Search for New Therapeutic Agents

  2016cites this paper
• Exploring the conformational and binding properties of unphosphorylated/phosphorylated monomeric and trimeric Bcl‐2 through docking and molecular dynamics simulations

  2016cites this paper
• Nerve growth factor alters microtubule targeting agent-induced neurotransmitter release but not MTA-induced neurite retraction in sensory neurons.

  2016cites this paper
• A review of the ligands and related targeting strategies for active targeting of paclitaxel to tumours

  2016cites this paper
• MicroRNA-16 sensitizes breast cancer cells to paclitaxel through suppression of IKBKB expression

  2016cites this paper
• RPL13A as a reference gene for normalizing mRNA transcription of ovarian cancer cells with paclitaxel and 10-hydroxycamptothecin treatments.

  2015cites this paper
• Class III β-tubulin in normal and cancer tissues.

  2015cites this paper
• ResearchThe conformation change of Bcl-2 is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in SGC 7901 human gastric cancer cells

  2015cites this paper
• Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells.

  2015cites this paper
• Nuclear Receptor TR3/Nur77 and Cancer Therapy

  2015cites this paper
• Original Article Nek6 and Hif-1α cooperate with the cytoskeletal gateway of drug resistance to drive outcome in serous ovarian cancer

  2015cites this paper
• Non-genomic effects of the NR4A1/Nur77/TR3/NGFIB orphan nuclear receptor.

  2015cites this paper
• Nuclear receptor 4A1 as a drug target for breast cancer chemotherapy.

  2015cites this paper
• Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response.

  2015cites this paper